http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2248536-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01a96e8bbea00eeaa0b50c2a0c000dba
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H04N17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H04L43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H04L12-2801
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0061
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H04N17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H04N7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H04L12-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H04L12-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H04L12-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
filingDate 2001-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77967ea119d2e9d5832be4c4ab8c83de
publicationDate 2010-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2248536-A3
titleOfInvention Topical Aminolevulinic acid-photodynamic therapy for acne vulgaris
abstract Light treatments of sebaceous gland disorders with 5-aminolevulinic acid and photodynamic therapy are disclosed. A preferred treatment includes topical application of 5-aminolevulinic acid to the skin followed by light exposures with repeated treatment at various intervals. At low doses of ALA and photodynamic therapy (PDT) in single or multiple treatments, improvement in the sebaceous gland disorder, e.g., acne, provides the discovery that diminishment in sebum secretion and the eradication of bacteria occurs. At high doses of ALA and a single high energy PDT treatment, permanent changes to the sebaceous gland and sebum secretion have been discovered.
priorityDate 2000-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5955490-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0155092-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129901017

Total number of triples: 24.